PICH deficiency attenuates the progression of lung adenocarcinoma and disrupts the DNA damage response

Miao Li; Weina Lu; Jiafei Lou; Gaoying Chen; Yinghui Yu; Yinfang Wu; Fei Li; Chao Zhang; Haoyu Tang; Qingyu Weng; Kua Zheng; Shenwei Gao; Yanping Wu; Chen Zhu; Min Zhang; Fangyi Yu; Rui Jin; Zhihua Chen; Xinwei Geng; Songmin Ying; Wen Li

doi:10.1002/ctm2.70349

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (5) : e70349 DOI: 10.1002/ctm2.70349

LETTER TO THE JOURNAL

PICH deficiency attenuates the progression of lung adenocarcinoma and disrupts the DNA damage response

Author information +

History +

PDF

Cite this article

Download citation ▾

Miao Li, Weina Lu, Jiafei Lou, Gaoying Chen, Yinghui Yu, Yinfang Wu, Fei Li, Chao Zhang, Haoyu Tang, Qingyu Weng, Kua Zheng, Shenwei Gao, Yanping Wu, Chen Zhu, Min Zhang, Fangyi Yu, Rui Jin, Zhihua Chen, Xinwei Geng, Songmin Ying, Wen Li. PICH deficiency attenuates the progression of lung adenocarcinoma and disrupts the DNA damage response. Clinical and Translational Medicine, 2025, 15(5): e70349 DOI:10.1002/ctm2.70349

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Chen X, Agustinus AS, Li J, DiBona M, Bakhoum SF. Chromosomal instability as a driver of cancer progression. Nat Rev Genet. 2025; 26(1): 31-46.

[2]	Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023; 20(9): 624-639.

[3]	Nielsen CF, Huttner D, Bizard AH, et al. PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis. Nat Commun. 2015; 6: 8962.

[4]	Castejón-Griñán M, Albers E, Simón-Carrasco L, et al. PICH deficiency limits the progression of MYC-induced B-cell lymphoma. Blood Cancer J. 2024; 14(1): 16.

[5]	Yang H, Zhen X, Yang Y, et al. ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle. J Exp Clin Cancer Res. 2023; 42(1): 227.

[6]	Győrffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation. 2024; 5(3): 100625.

[7]	Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020; 38(6): 675-678.

[8]	Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022; 25: 18-27.

[9]	Boon NJ, Oliveira RA, Körner PR, et al. DNA damage induces p53-independent apoptosis through ribosome stalling. Science. 2024; 384(6697): 785-792.

[10]	Tong X, Chen Y, Zhu X, et al. Nanog maintains stemness of Lkb1-deficient lung adenocarcinoma and prevents gastric differentiation. EMBO Mol Med. 2021; 13(3): e12627.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.